Sparrow E, Adetifa I, Chaiyakunapruk N, Cherian T, et al. WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use. Vaccine 2022;40:3506-3510.
PMID: 35184927